Trial intelligence / Profile preview

Duloxetine for chronic low back pain after posterior spinal fixation

IRCT20191210045685N1Phase 3Completed

Sponsor
Iran University of Medical Sciences
Start
Jun 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial in chronic low back pain (CLBP) comparing Duloxetine with Placebo (2 arms). Primary endpoints: Change in quality of life and Change in pain severity. Started Jun 2019; status: completed.

02

Drugs

duloxetine
03

Conditions

chronic low back pain (CLBP)

Beyond the preview

Go deeper on IRCT20191210045685N1.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20191210045685N1.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call